Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

10.1 Hopf

286 views

Published on

  • Be the first to comment

  • Be the first to like this

10.1 Hopf

  1. 1. Institut universitaire romand de Santé au Travail Institut für Arbeit und Gesundheit Institute for Work and Health Skin permeation and metabolism of di(2-ethylhexyl) phthalate (DEHP) 16.05.2013 Nancy B Hopf, Aurelie Berthet, David Vernez, Emilie Langard, Philipp Spring, René Gaudin
  2. 2. Background • High-molecular-weight phthalates (HMWP) are used in plastic tubing, food packaging and processing materials, containers, vinyl toys, vinyl floor coverings, and building products • Phthalate exposures have produced a variety of male reproductive effects • Phthalates are assumed to have low dermal absorption however this is based on a few dermal absorption studies excluding the skin’s possibility to metabolize phthalates • Skin permeation rates used in dermal exposure assessments might therefore underestimate the absorbed dose in health risk assessments. 2
  3. 3. Biological monitoring • Urinary metabolites MEHP, 5OH-MEHP, 5oxoMEHP, 5cx-MEPP, and 2cx-MMHP are collected post shift • 5cx-MEPP is the primary metabolite in humans1 • Half lives 2 - 24 hours2 1 Wittassek and Angerer, 2008 2 Koch and Angerer, 2007; Koch et al., 2005 3
  4. 4. Workers’ exposures • High exposures during manufacturing of products containing phthalates1 • Urinary metabolite concentrations often exceed the 95th percentile of the general population2. • HMWPs are not very volatile, but readily form airborne aerosols possibly inhaled by workers during work with heated processes3 • Urinary HMWP metabolites are present after non-heated processes. Can dermal exposures potentially play a role in non-heated processes? • • • 1 Gaudin et al., 2011; Gaudin et al., 2008; Hines et al., 2008; Hines et al., 2009; Koch et al., 2012 2 NRC 2008 3 Smith et al., 1980 4
  5. 5. Dermal exposure during non-heated processes • workers preparing DEHP-containing plastisol at room temperature and supervising the plastisol coating of glass flasks automatically dipped into vats filled with the plastisol - elevated 5cx-MEPP (median 107.5 μg/L)1. • workers manufacturing vehicle filters with DEHP-based plastisol - elevated 5OH-MEHP and 5oxo-MEHP (44.0 and 34.3 μl/L, respectively)2. • workers refinishing sealants at room temperatures – elevated DiNP/DiDP metabolite concentrations3. 1 Gaudin et al., 2011; Gaudin et al., 2008 2 Hines et al., 2008 3 Koch et al., 2012 5
  6. 6. Experimental Design Hypothesis Dermal uptake is a significant contributor in overall DEHP exposure at room temperature Aims 1. Determine DEHP lag time (τ), permeation rate (J) and permeation coefficient (Kp) 2. Assess extent of DEHP skin metabolism 3. Estimate skin absorption in a simple occupational exposure task using the obtained permeation parameters.
  7. 7. Materials and Methods • Human skin preparation • Flow-through diffusion cells Chemicals: DEHP, d4DEHP, MEHP, Receptor fluid: cell culture media (RPMI-1640) 7
  8. 8. Results: neat vs. aq DEHP Chemical Applied n Chemical Measured Dose (mg) Concentration (µg/mL) Kp cm/h) (10-5 J (µg/h cm2) AM±SD Τlag (h) d4-DEHP (aq) 4 d4-MEHP 50 166 15.1 0.025±0.021 8 DEHP (neat) 4 MEHP 980* Neat 0.13 0.0013±0.0017 30 8
  9. 9. Results: MEHP applied to skin Chemical Applied Chemical Measured n Dose (mg) Concentration (µg/mL) Kp (10-5 cm/h) J (µg/h cm2) AM±SD Τlag (h) MEHP (aq) 6 MEHP 50 166 436.1 0.724±0.23 6 MEHP (aq) 5 5OH-MEHP 50 166 0.02 0.0004±0.0003 6 9
  10. 10. Dermally absorbed dose (DAD) mg/kg/day • Workplace scenario: A vat with DEHP (166 μl/ml or neat), opened once per day, 200 times per year, both hands immersed (800 cm2) for 3 min 𝐷𝐴𝑒 𝑣 𝑒 𝑛 𝑡∗𝐸𝑉∗𝐸𝐷∗𝐸𝐹∗𝐴 𝐷𝐴𝐷 = 𝐵𝑊∗𝐴𝑇 • • DAevent absorbed dose per event (mg/cm/event) = 𝐾𝑝 ∗ 𝐶 ∗ 𝑡 where Kp (cm/h) is the coefficient of percutaneous permeation obtained in our study and by Ng et al., 1992, C is the concentration of DEHP applied to the skin (mg/L) t is the duration of exposure (h) EV event frequency (events/day) ED exposure duration (years) EF exposure frequency (days/year) A skin surface area (cm2) BW body weight (kg) AT average time in days for non-carcinogens AT = ED 0.27*10-5 1.66 0.16 1 1 200 800 70 1 DEHP (aq): 2.85*10-2 mg/kg/day (Kp 15.1 * 10-5 cm/h) DEHP neat: 1.49*10-4 mg/kg/day (Kp 0.13 * 10-5 cm/h) 10
  11. 11. Dermally absorbed dose (DAD) • The dermally absorbed dose (DAD) estimated for the maintenance task for a) DEHP in aqueous solution was I. 2.85*10-2 mg/kg/day using our Kp (15.1 * 10-5 cm/h) and II. 1.02*10-2 mg/kg/day using the Kp (0.27 * 10-5 cm/h) obtained by Ng et al., 1992 b) DEHP neat was 1.49*10-4 mg/kg/day (Kp 0.13 * 10-5 cm/h) 11
  12. 12. Discussion Total dermal DEHP dose DAD was • ~200 times greater for waterbased compared to neat solution • ~ 3 times greater than using Kp from published papers (Ng et al., 1992) • > the daily intake calculated for the general population in Germany (Wittassek et al., 2007) • > the US EPA reference dose • < the European Food Safety Authority (EFSA) Tolerable Daily Intake (TDI) • ~ estimated daily intake previously estimated for workers manufacturing or using DEHP (Hines et al., 2008, 2011) 12
  13. 13. Discussion • Older studies concluded that DEHP permeation was negligible; however, few used viable skin, mostly animal skin, and did not measure metabolites • In vitro skin permeation (Kp) previously reported for DEHP ranged from 0.011 to 94 x 10-5 cm h-1 (ours 15 x 10-5 cm h-1 DEHP (aq)) • Recent phthalate skin permeation studies (DBP) have shown similar skin metabolism results 13
  14. 14. Discussion • Other permeability determinants not explored were – choice of reservoir fluid – skin type (animal versus human, gender, age, type) – storage (fresh and frozen) – skin thickness – SC separation methods (heat, NaBr, dermatomed) • The vast number of permeability determinants complicates comparisons with other studies. • Human skin variability is large 14
  15. 15. Discussion • The rate was primarily determined by whether DEHP was applied neat or in aqueous solution – DEHP (neat) will reluctantly diffuse into the comparatively less lipophilic SC (Tlag>30 h) – DEHP (aq) have less affinity to water and prefer the lipophilic SC as seen with the much higher permeation rate. – Similar permeation rates DEHP (aq) and MEHP (aq) the rate limiting step is the availability of DEHP in the dermis (aqueous phase) and not the metabolism step. – DEP skin permeation rates were almost double for DEP applied as a saturated aqueous solution compared to neat. – chemical enhancers commonly used to increase drug delivery are alkyl esters, making phthalate diesters eloquent pro-drugs 15
  16. 16. Conclusion • Absorption of DEHP through the dermal route is significant, and not as currently regarded: negligible or low. • Both DEHP and MEHP have shown low antiandrogenicity effect and can bind to estrogen receptors in the skin (ERα and ERβ). What endocrine effects this might exert is currently unknown and needs further scrutiny. Acknowledgement: We thank the Swiss Centre for Applied Human Toxicology (SCAHT) for funding this study. 16
  17. 17. Thank you for your attention Nancy B. Hopf Institute for Work and Health University of Lausanne and Geneva

×